Cargando…
Lysosomal TRPML1 regulates mitochondrial function in hepatocellular carcinoma cells
Liver cancers, including hepatocellular carcinoma (HCC), are the second leading cause of cancer death worldwide, and novel therapeutic strategies are still highly needed. Recently, the endolysosomal cation channel TRPML1 (also known as MCOLN1) has gained focus in cancer research because it represent...
Autores principales: | Siow, Wei Xiong, Kabiri, Yaschar, Tang, Rachel, Chao, Yu-Kai, Plesch, Eva, Eberhagen, Carola, Flenkenthaler, Florian, Fröhlich, Thomas, Bracher, Franz, Grimm, Christian, Biel, Martin, Zischka, Hans, Vollmar, Angelika M., Bartel, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977057/ https://www.ncbi.nlm.nih.gov/pubmed/35274126 http://dx.doi.org/10.1242/jcs.259455 |
Ejemplares similares
-
Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells
por: Plesch, Eva, et al.
Publicado: (2018) -
Mitochondrial Impairment by MitoBloCK-6 Inhibits Liver Cancer Cell Proliferation
por: Kabiri, Yaschar, et al.
Publicado: (2021) -
Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function
por: Geisslinger, Franz, et al.
Publicado: (2022) -
Aza Analogs of the TRPML1 Inhibitor Estradiol Methyl Ether (EDME)
por: Rühl, Philipp, et al.
Publicado: (2023) -
Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review
por: Geisslinger, Franz, et al.
Publicado: (2020)